Samples from four hypogammaglobulinemic moth ers and their newborns as well as two Ig/v-deficient moth ers and their neonates were studi ed. Mother I whose first infant was investigated earlier (1), now had her second baby investigated. From mother II samples from two pregnancies were included. At delivery, we tried to obtain am niotic fluid, cord serum , and mother's serum. Cord blood was taken from the placental side of the umbilical cord. All samples were frozen at -20ce . Du ring the first few days postpartum, mother's and infant's saliva, meconium, and maternal milk (not included in this study) were collected. Samples were frozen immediately at -20°C. The babies had not been given either the mother's or bank milk before the sample was taken. Th e time passed from the last feeding was recorded, as was the mode of feeding. Th e saliva was obtai ned as unstimulated whole saliva with a l-mL syringe or a rounded eye-drop pipette during 15 min and was immediately frozen at -20°C.
ABSTRACT. To explain the mechanism for induction and production of specific antibodies found in the newborn alread y at birth, without previous known exposure to the antigen, we chose a model that presumably excluded the possibility of specific antibodies being transferred from the mother to the fetus. Specific IgG, IgA, and IgM antibodie s against Escherichia coli and poliovirus antigens were determined with ELISA in serum, saliva, and amniotic fluid from hypogammaglobulinemic and IgA-deficient mothers as well as in cord serum, sali va, and meconium from their offspring. All the mothers lacked IgA and some also lacked IgM antibodies , which were found in their healthy newborns. The amniotic fluid from a hypogammaglobulinemic mother lacking IgA contained small amounts of Igaantibodies, which were also found in the neonate, suggesting a fetal origin. There was evidence for the presence of antiidiotypic antibodies to poliovirus in the cord sera. We propose that idiotypic and/or antiidiot ypic IgG antibodies transferred via the placenta from the mother to the fetus can initiate specific immune responses seen in the newborn. Thus, it may be that transplacental IgG not only passively protects the newborn, but also actively primes the fetus during fetal life via its content of idiotypic and/or antiidiotypic antibodies. (Pediatr Res 32: 150-154, 1992) Abbreviations NMS, normal mouse serum PBS -T, phosphate buffered saline with Tween RF, rheumatoid factor SC, secretory component
In an earlier study, we found specific secretory IgA and IgM antibodies to a pool of Escherichiacoli 0 antigens and poliovirus type I antigen in amniotic fluid, saliva, and meconium of newborn s already at birth ( I). It was unlikely that these antibodies were of materna l origin, inasmuch as 19A and IgM are not known to pass the placenta. Furthermo re, an infant of a hypogammaglobulinemic mother without detectable IgA and IgM antibodies had specific IgA and IgM antibodies in saliva against E. coli 0 a ntigen as well as poliovirus type I antigen already at birth ( I). The presence of antibodies to poliovirus in Swedish newborns was especially difficult to explain, inasmuch as wild or vaccine strains of poliovirus do not circulate in the community because close to 99% of the popul ation has been efficiently vaccinated using inactivated poliovirus vaccine exclusively. The refore, the fetu ses were unlik ely to have been exposed to poliovirus antigen in utero, suggesting that the secretory 19A and IgM antibodies had been produ ced by the fetus in response to another stim ulus, e.g. idiotypic and/or antiidiotypic antibodies to poliovirus. Such antibodies were dem onstrated in the Ig preparation given prophylactically to the mothers with hypogammaglobulinemia (Hahn-Zoric M, Carlsson B, Jeansson S, Ekre HP , Osterhaus ADME, Roberton D, Hanson LA., unpublished data).
In the present study, we have tested a group of hypogammaglobulinemic or Ig/v-deficient mothers and their newborn s to further analyze antibodies appearing in the neon ate that presumably could not have come from the mother. (Table 1) . Antigen-specific Ig were analyzed in a modified ELISA (3,4), using hard, polystyrene microtiter plates with flat bottoms (Dynatech, Alexandria, VA or NUNC Immunoplate I, Roskilde, Denmark). The sensitivity of this method allows detection of < 1 ng/rnl, of specific antibody. The plates were coated either with a pool of 10 common E. coli 0 antigens or with a concentrated inactivated poliovirus type 1 vaccine to 95% composed of Dantigen and produced at the Rijksinstituut voor Volksgezondheid en Milieuhygiene, Bilthoven, the Netherlands. Rabbit antisera against human IgA (a-chain specific),IgM (u-chain specific),and IgG (v-chain specific) (Dakopatts, Copenhagen, Denmark), as well as sheep anti-human SC (Seward Lab, London, UK), were conjugated to alkaline phosphatase (Boehringer Mannheim, Mannheim, Germany) and used for determination of antibodies in amniotic fluid, saliva, cord blood, and serum. The reaction between alkaline phosphatase and enzyme substrate (1 mg/rnl, of p-nitro-phenyl-phosphate disodium; Sigma Chemical Co., St. Louis, MO) in 1 M diethanolamine buffer, pH 9.8, containing 0.001 M MgCb was read in a Titertek Multiscan (Flow Labs, Ayrshire, Scotland) at 405 nm after appropriate reaction time, whereas the enzyme-substrate reaction was linear and then usually extrapolated to 100 min. Because of the presence of high concentrations of alkaline phosphatase in meconium, a double antibody ELISA was used instead for this material, using rabbit antisera against human IgA, IgM, or SC (Dakopatts) as primary antibody. As second antibody, goat anti-rabbit -y-chain-specific rabbit IgG conjugated to iJ-galactosidase (Southern Biotechnology AssociatesInc., Birmingham, AL) was added. O-nitrophenyliJ-D-galactopyranoside (Sigma) in a concentration of 1.4 mg/ml, in 0.2 M phosphate buffer, pH 7.0, containing 2.0 mM MgCb was used as enzyme substrate. The plates were read at 405 nm as above. All the samples were run in four lO-fold dilutions, starting from undiluted for meconium and amniotic fluid, 1:5 for saliva and 1:100 for serum and cord serum.
The antibody levels were expressed as a percentage of a reference that was a human early milk pool diluted 1:10 for IgA, IgM, and SC in secretions and amniotic fluid and a serum standard diluted 1:100 for IgG as well as for serum and cord blood IgA and IgM. The serum standard used was a high-titered single patient's serum collected by plasmaphoresis and defibrinized. It was previously tested against a commercial serum pool and has been used in our laboratory during the last two decades.
The standards were used in each assay to ensure the inter-and intraassay reproducibility of the method, which was < 10% and <5%, respectively. Determination ofantiidiotypic antibodies. Cord blood samples from the newborns of three hypogammaglobulinemic and one IgA-deficient mother were tested in two specially designed and previously used ELISA for the detection of antiidiotypic antibodies against poliovirus type 1 (5). NUNC plates were coated with mouse monoclonal IgG antibodies to poliovirus type 1, desig- After incubation overnight at 37°C, blocking was done with 1% fish gelatin (Sigma) in PBS for 1 h at room temperature. In the direct binding assay, cord serum samples were added to the plates in 10-folddilution series in 1% gelatin-PBS-T and 10% NMS (Calbiochem, Behring Diagnostics, La Jolla, CA). After 4 h incubation at room temperature, alkaline phosphatase-conjugated (Fab), mouse anti-human IgG (Jackson Immuno Research Laboratories Inc., West Grove, PA) diluted 1:5000 in 1% gelatin-PBS-T was added, and after incubation overnight at room temperature the enzyme substrate was added and the plates were read as described above. Sample-free and antibody-free controls were included to check any unspecific binding. The competitive inhibition assay used is based on the ability of antiidiotypic antibodies to inhibit the binding of antigen to the homologous antibody. The cord sera were added to the plates coated with antibodies to poliovirus in a dilution of 1:200 in 10% NMS-l % gelatin-PBS-T as above. After incubation for 4 h at room temperature, poliovirus type 1 antigen was added in appropriate dilutions in 1% gelatin-PBS-T. After incubation overnight at 4°C, the polyclonal rabbit anti-poliovirus type 1 antibody diluted 1:1000 in 10% NMS 1% gelatin-PBS-T was incubated in the plates for 4 h at room temperature. Alkaline phosphatase-conjugated goat anti-rabbit IgG (Fab), fraction (Sigma) diluted 1:1000 in 10% NMS-l % gelatin-PBS-T was added to the plates, and after 3 h incubation at 3rC the substrate was added and the plates were read as indicated above. Samplefree, antigen-free, sample and antigen-free, and MAb-free controls were used to exclude any nonspecific binding between the different reagents.
Detection ofRF. Cord sera from the infants of three hypogammaglobulinemic and one IgA-deficient mother were negative in a class-specific diffusion-in-gel ELISA for determination of RF (6) . In a more sensitive direct ELISA described above, there is a possibility that RF, if present, may give false-positive results when determining the antiidiotypic antibodies against poliovirus type 1. The nonspecific binding of the RF to the Fe portion of either coated mouse MAb or human antiidiotypic antibody would enhance the detection by the conjugated antibody.
An optimal dilution of each sample was mixed with different dilutions of isolated Fe fragments ofIgG (kindly given by Dr. B. G. Johansson, Dakopatts) for 1 hat 3rC before being added to the plates coated with two MAb (5D9D6 and 7D7D8) and the polyclonal anti-polio antibody. Thus, the free Fe would bind to any RF present, blocking their binding to the unwanted sites, preventing interference with the assay. An RF-negative and a strongly RF-positive serum were used as controls as well as an Fc-free control for each sample.
Specificity controls. Control experiments ensuring the specificity of antigen-antibody binding, as well as inhibition experiments proving the specificity of antigens used, were performed (7).
RESULTS

Antibodies in hypogammaglobulinemic mothers and their newborns.
All three mothers with available sample had IgG antibodies against both the E. coli and poliovirus antigens in the amniotic fluid, and in the sample from the first pregnancy of mother II there were low levels of IgM antibodies as well. Amniotic fluid from her second pregnancy contained very low levels of IgA antibodies against poliovirus type 1 antigen; such antibodies were not detectable in the mother's serum (Table 2 ).
In the sera of all the mothers, we found high levels of IgG antibodies against poliovirus type 1 antigen and about half of the reference value against E. coli 0 antigens (Table 2) . Mothers I, III, and IV had no IgA or IgM in their sera, whereas mother II had no IgA and very low levels of IgM. Newborns of mothers I, II, and III had only IgG antibodies in their cord sera, but the t NT, not tested.
t Underlining signifies antibodies found in the newborn but not in the mother. § ND, not done due to insufficient volumes or unavailable sample.
II Antibodies found in the second child of mother II that were not found in the mother.
\! Trace = < I %.
newborn of mother IV had serum IgM antibodies against E. coli o antigens.
Salivary antibodies in all fou r mothers were negative for 19A and IgM antibodies. Mothers I, II, and IV had no SC-carrying antibodies either, but mother III had such antibodies in her saliva. IgG antibodies were found in the saliva of all three mothers.
All four new bo rns had 19A, IgM , and SC-carrying antibodies against both antigens in their secretions, e.g. saliva and/or meconium ( Table 2 ). The neonates had such a ntibodies although they were missing in thei r mothers (underlined values in Table  2 ).
Antibodies in Ign -defi cient m others and their newborns. Amniotic fluid was available only from mother VI. Besides IgG , it al so contained high levels of IgM antibodies and low levels of 19A and SC-co ntaining antibodies (Table 3) .
Both m others ha d serum IgG that was high against poliovirus and lower against E . coli 0 antigens with vary ing levels of IgM antibodies (Table 3 ). In the one cord serum available (fro m newborn V), there were IgG antibodies against both antigens at hig her levels than in the mother's serum and also low levels of serum 19A and IgM again st poliovirus type I ( Table 3) .
The saliva was available only from mother V. 19A antibodies we re undetectable in her saliva , but both she and her new born had elevated salivary IgM antibodies. Both newborns, however, had 19A antibodies in saliva against both antigens. Also , they both had SC-containing antibodies a nd the newborn of mother V had IgG a nd IgM as well, wh ereas the saliva of the newborn of m other VI contained no IgG and no IgM against poliovirus on the first da y after deli very .
There were IgM and/or 19A antibodies in meconium from the newborns sam pled on a few different occasions. Neonate VI had 19A antibodies against poliovirus type I up to 5% of the reference and a trace ofIgM antibodies against both antigens in meconium. IgM antibodies against poliovirus type I were found in meconium of infant V. Traces of 19A antibodies were also found in th e in fant ofmother V, althou gh such an tibodies were not present in th e mother (Table 3) .
Antiidiotypic antibodies in cord sera. All four cord sera analyzed sho wed in the direct assay binding of antibodies to the m urine MAb against poliovirus type I antigen as well as to the bo vine pol yclonal IgG against po liovirus type 1 antigen (T able 4). There were indications that some cord sera bound better than ot hers to the different idiotypes against pol iovirus. We found no evidence that RF interfered with this direct assay. Fe-free sam ples and mixtures of samples with different concentrations of Fe gave the same readings as did the RF-negative and RF-positive seru m.
In th e competitive assa y, all the cord sera could inhibit the binding of po liovirus type I antigen to at least one of the MAb and to the pol yclonal antibody against poliovirus type 1 antigen . The level of inhibition varied again among the four individuals and the d ifferent idiotypes (Table 5) .
DISCUSSION
In the present st udy, we ha ve demonstrated that newborn infants of hypo gammaglobulinernie or IgA-deficient mothers ca n *Underliningsignifies antibodies found in the newborn but not in the mother. § ND, not done due to insufficient volumes or unavailablesample.
II Trace = <I %.
* Mean of duplicate determinations.
Absorbance at I: 10 dilution of cord sera and after 20 min reaction time* (8) . Comparing these antibody levels to a breast milk reference pool, they exceeded the normal levels severalfold. The IgA-deficient mothers also had greatly increased levels of IgG antibodies in milk and sometimes extremely elevated levels of IgM as well (8) . That might be a part of a compensating mechanism in these mothers. The antibodies in amniotic fluid could be produced either by mother or fetus. In the amniotic fluid from one hypogammaglobulinemic mother who had low levels of IgM antibodies in her serum, low levels of IgM antibodies were found. Thus, the origin of that IgM was not clear. However, the very low levels of IgA antibodies found in the amniotic fluid of the second child of mother II speak in favor of fetal production, because the mother totally lacked such antibodies. Of the two IgA-deficient mothers, only one had available amniotic fluid, and the origin of the IgM antibodies found was not obvious because the mother compensated well with IgM antibodies. In this amniotic fluid, low levels of IgA and SC-containing antibodies were also demonstrated. Their origin was not certain either, inasmuch as this mother had no available salivary sample for analyzing, but it could possibly be of fetal origin because individuals lacking serum IgA almost in all instances are also lacking this Ig in their secretions.
The mothers with hypogammaglobulinemia and their infants had IgG antibodies to poliovirus type I antigen in their sera presumably originating from the Ig preparations given to these mothers and known to contain idiotypic and antiidiotypic anti- Animal experiments have earlier demonstrated that idiotypes and antiidiotypes can prime newborn mice to respond more efficiently to immunization with protection against subsequent challenge with live bacteria (9) . The priming effect was also demonstrated when mothers were immunized with antiidiotypes shortly after delivery. Their suckling offspring were protected from challenge with E. coli as well. Okamoto et al. (10) showed that neonatal mice can be protected by idiotypes transferred via the mother's milk, either by a priming effect to subsequent the infants had such antibodies although they were not found in their mothers. These fetuses were unlikely to have been exposed to poliovirus in utero. Exposure to E. coli 0 antigens cannot be excluded. We presume that these IgM and IgA antibodies have been produced by the fetuses themselves, because the samples were collected at delivery before any breast milk was given. When milk samples from the hypogammaglobulinemic mothers were analyzed, they contained exclusively IgG antibodies against antigen challenge or by passively transferred protection. We have recently shown that breast-feeding seemed to enhance serum and secretory antibody responses to peroral poliovirus and parenteral tetanus and diphtheria toxoid vaccines in infants, possibly because of the presence of idiotypic and/or antiidiotypic antibodies in mother's milk. Even 2-3 y later, the serum antibody levels were higher in the breast-fed compared to the formula-fed infants (11) . We have also found evidence for antiidiotypic antibodies against poliovirus type 1 in human milk (Hahn-Zoric M, Carlsson B, Jeansson S, Ekre HP, Osterhaus ADME, Roberton D, Hanson LA, unpublished data). A similar enhancement of the response to the Bacillus Calmette-Guerin and conjugate Haemophilus influenzae type b vaccines by breast-feeding was also reported (12, 13) . In intrauterine infections, the fetus is capable of an immune response against infecting microorganisms (14) . Idiotypic sensitization in utero has also been demonstrated in children born to mothers with chronic parasitic infections. These children were born with T lymphocyte-mediated antiidiotype reactivity, a priming that might be important if they became infected (15) . The fetus can produce specific antibodies against antigens to which the mother has been vaccinated during pregnancy as well (16, 17) .
Transient synthesis of antibodies to the acetylcholine receptor has been demonstrated in newborns with neonatal myasthenia gravis, born to myasthenic mothers (18) . The receptor antibodies found at birth in the symptomatic infants were often of different idiotypes than those found in their mothers. El-Roeiy et al. (19) have shown that infants of mothers with systemic lupus erythematosus had autoantibodies that were absent in the mothers. This indicated fetal autoantibody production.
It was recently shown in an animal model that oral immunization with xenogeneic antibodies results in both systemic and mucosal anti-Ig responses (20) . Female rabbits were fed with murine 19A antibody and their serum and colostrum samples contained antiidiotypic antibodies against the murine antibody, some of which were antibodies directed against the antigenbinding site. This was determined by a competitive inhibition assay. Another indication that an immune response in different species elicits the formation of antibodies that express a common idiotype was provided by an observation that a murine MAb specific for ryegrass pollen allergen Lol p IV, could inhibit the binding of a mouse, human, and rabbit antisera to Lol p IV (21) . Furthermore, the same antisera to Lol p IV could inhibit the idiotype-antiidiotype interactions. Thus, the monoclonal antiidiotypic antibody was characterized as an internal image antiidiotype.
It was found in adult mice that immunization with the antiidiotypic antibodies to poliovirus could successfully induce neutralizing poliovirus antibodies (22) . In the present study, we have demonstrated direct binding and inhibition of poliovirus antigenbinding to antibodies against poliovirus with cord sera from infants of mothers with 19A deficiency or hypogammaglobulinemia. We propose that this reactivity is due to the presence of antiidiotypic antibodies to poliovirus antigens in these cord sera. Because the balance between the idiotypic and antiidiotypic antibodies may play an important role in the regulation of the normal immune response, their presence in the fetus may also have an impact on the fetal immune response. Idiotypes and/or antiidiotypes, transferred from the mother may prime the fetus and enhance its own capacity to produce protective antibodies. On the other hand, it may be possible that sensitization to common allergens, e.g. food allergens, may occur via the same mechanism.
